Primary progressive aphasia (PPA) is a syndrome that arises when the language-dominant (usually left) hemisphere is selectively targeted by a neurodegenerative disease. The underlying neuropathology can be either frontotemporal lobar degeneration (FTLD) or an atypical form of Alzheimer disease (AD). 1 The factors that make the language network selectively susceptible to these neurodegenerative diseases remain unknown. One potential clue emerged from our previous report, which showed a history of learning disability (LD), including developmental dyslexia, to be significantly higher in patients with PPA (n = 108) and their first-degree relatives than in cognitively healthy control individuals (n = 353), as well as dementia of the Alzheimer type (n = 154) or the behavioral variant of frontotemporal dementia (n = 84).
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The prevalence of LD in logopenic PPA (PPA-L) was reported to be approximately twice the rate expected in the general population.
3 Logopenic PPA is the subtype most commonly caused by AD, raising the possibility that LD becomes a particularly prominent susceptibility factor for the atypical aphasic manifestation of AD. In our initial report, clinical subtype was not considered and autopsies were not available. The current follow-up study examined 66 consecutive autopsies of patients with PPA to determine whether the presence of LD in either patients or their first-degree family members was associated with a specific aphasia subtype or pathology. In this group, 58 patients with PPA had sufficient information on the status of LD and were included in analyses. Twenty of these were part of our previous report. Results | Fifty percent of the cases (29 of 58 patients) had either a personal or family history of LD. This is even higher than the 37% prevalence in our original report but the difference was not statistically significant (P = .10, Fisher exact test). Demographics did not differ between the groups with and without a history of LD (Table) . The LD prevalence in PPA with AD (52%) was nearly identical to that in PPA with FTLD (48%). There were too few cases for separate analyses of FTLD subtypes. The incidence in PPA-L (41%) was no greater than that of the nonlogopenic patients (56%). Although the numbers were low, LD prevalence in agrammatic PPA (53%) did not seem to be higher than in nonagrammatic patients (49%).
Discussion | This set of 58 autopsies yielded an LD prevalence that was at least as high as that in our original study. The prevalence was higher than reported by Miller et al, 3 probably because we also included incidence in first-degree relatives and were more inclusive in defining LD. Our findings are consistent with the report by Miller et al 3 of a high LD prevalence in PPA-L. However, we did not find that LD was preferentially associated with AD vs FTLD pathology or with PPA-L vs other PPA variants. If LD does turn out to be a susceptibility marker for PPA, at least in some patients, it would seem to be exerting its influence regardless of the underlying pathology or aphasia type. Larger cohorts and greater specification of the LD history will help to refine and amplify these associations. 
